Connection

Chadrick Denlinger to Cohort Studies

Back to Details
This is a "connection" page, showing publications Chadrick Denlinger has written about Cohort Studies.
Chadrick Denlinger
Connection Strength
0.029
Cohort Studies
  1. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan; 75(1):17-23.
    View in: PubMed
    Score: 0.020
  2. Pulmonary segmentectomy: results and complications. Ann Thorac Surg. 2003 Aug; 76(2):343-8; discussion 348-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.